From organelles to therapy: rethinking combined hepatocellular-cholangiocarcinoma
Tiezhong Zhang, Kangshuai Li, Qi Li, Qiang Gao, Lixin Du, Jian Deng, Zhuohan Cao, Sen Guo, Zongli Zhang · 2026
Read From organelles to therapy: rethinking combined hepatocellular-cholangiocarcinoma by Tiezhong Zhang, Kangshuai Li, Qi Li, Qiang Gao, Lixin Du, Jian Deng, Zhuohan Cao, Sen Guo, Zongli Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13124961.txt.
Description
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary malignant hepatic neoplasm, defined by the concurrent presence of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) components, which vary in proportion and degree of differentiation. Characterized by insidious onset, high invasiveness, and marked heterogeneity, cHCC-CCA often eludes early diagnosis, leading to a generally dismal prognosis.
Catalog record
| CREATOR | Tiezhong Zhang, Kangshuai Li, Qi Li, Qiang Gao, Lixin Du, Jian Deng, Zhuohan Cao, Sen Guo, Zongli Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |